Healthcare analysts are out with commentary on biotech stocks Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP).
Two clinical stage biopharmaceutical companies, Arrowhead Research Corp (NASDAQ:ARWR) and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), both provided a data update on pipeline drugs.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) was up 9% in pre-market trading this morning following positive data from its CD19-specifict CAR T-cell therapy programs.
CTI BioPharma Corp CTI BioPharma Corp (NASDAQ:CTIC) shares are tumbling 16.24% to $0.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), a biopharmaceutical company focused on new cancer immunotherapies, today announced that the Company is presenting initial results from an ongoing Phase …
In a research note released Thursday, J.P.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) announced financial results for the third quarter ended September 30, 2015, and provided an update on the company’s recent …
J.P.
Intrexon Corporation (NYSE:XON), a leader in synthetic biology, announced it has formed a new Exclusive Channel Collaboration (ECC) with ZIOPHARM Oncology Inc.(NASDAQ:ZIOP), a …
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer immunotherapies, today announced the appointment of Scott Tarriff …
